Global Recombinant Proteins Market Size study, By Product (Antibodies, Hormones, Growth Factors, Enzyme, Cytokines, Others), By Application (Drug Discovery & Development, Biopharmaceutical Production, Biotechnology Research, Academic Research Studies, Other Applications), By End User (Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users), and Regional Forecasts 2022-2028
- BIZ4950961
- 200 Pages
- March 2022
- Diagnostic and Biotech
Recombinant proteins are the new amalgamation of genes that are primarily used to generate DNA. Recombinant DNA technology helps in the production of wild-type and modified human, mammalian proteins in bulk quantities. Recombinant protein formation needs a special method known as recombinant DNA (rDNA) technology. This protein is used for the development of new therapies for severe chronic diseases like cancer and other rare diseases. The increasing government funding and rising investment for R&D activities in pharmaceutical & biotechnology companies, and increasing incidences of chronic & infectious diseases are the primary factors that may augment the market demand across the globe. In addition, rising inclination toward biologics and biosimilars, technological developments in recombinant products, coupled with the increasing collaborations of the industry-academia are further chief driving factors for the market growth in the approaching years. For instance, in 2019, Thermo Fisher Scientific, Inc. collaborated with the Biopharmaceutical Analysis Training Laboratory (BATL) of Northeastern University. The aim of this collaboration is to develop analytical capabilities and to introduce novel innovations in the biopharmaceutical industry especially in applications like monoclonal antibodies, personalized medicine, and gene & cell therapies. Similarly, in 2020, Bio-Techne Corporation partnered with Elpiscience BioPharma with the objective of advancing anticancer therapeutics. This allows Elpiscience to access over Bio-Techne’s antibodies portfolio for developing the company’s preclinical, clinical, and commercial biopharmaceuticals. However, expensive and time-consuming production processes and safety concerns associated with recombinant proteins impede the growth of the market over the forecast period of 2022-2028. Also, the growing focus on personalized medicine and protein therapeutics and increasing expenditure on research and development activities are anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the global Recombinant Proteins Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the availability of favorable government funding and the increasing presence of major companies across the region. Whereas, Asia-Pacific is also anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as growing incidences of chronic & infectious diseases, as well as increasing spending on the R&D activities, would create lucrative growth prospects for the Recombinant Proteins Market across the Asia-Pacific region.
Major market players included in this report are:
Thermo Fisher Scientific, Inc.
Miltenyi Biotech
Sino Biological Inc.
Bio-Rad Laboratories, Inc.
Enzo Life Sciences, Inc.
BPS Bioscience, Inc.
Stemcell Technologies Inc
RayBiotech Inc
Richcore Lifesciences Pvt Ltd
United States Biological
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product
Antibodies
Hormones
Growth Factors
Enzyme
Cytokines
Others
By Application
Drug Discovery & Development
Biopharmaceutical Production
Biotechnology Research
Academic Research Studies
Other Applications
By End User
Pharmaceutical & Biopharmaceutical Companies
Biotechnology Companies
Academic Research Institutes
Contract Research Organizations
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Recombinant Proteins Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Global Recombinant Proteins Market, by Region, 2020-2028 (USD Million)
1.2.2. Global Recombinant Proteins Market, by Product, 2020-2028 (USD Million)
1.2.3. Global Recombinant Proteins Market, by Application, 2020-2028 (USD Million)
1.2.4. Global Recombinant Proteins Market, by End User, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Recombinant Proteins Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Recombinant Proteins Market Dynamics
3.1. Recombinant Proteins Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rising inclination toward biologics and biosimilars
3.1.1.2. Increasing prevalence of chronic & infectious diseases
3.1.2. Market Challenges
3.1.2.1. Expensive and time-consuming production process
3.1.2.2. Safety concern associated with recombinant proteins
3.1.3. Market Opportunities
3.1.3.1. Growing focus on personalized medicine and protein therapeutics
3.1.3.2. Increasing expenditure on research and development activities
Chapter 4. Global Recombinant Proteins Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Recombinant Proteins Market, by Product
6.1. Market Snapshot
6.2. Global Recombinant Proteins Market by Product, Performance - Potential Analysis
6.3. Global Recombinant Proteins Market Estimates & Forecasts by Product 2019-2028 (USD Million)
6.4. Recombinant Proteins Market, Sub Segment Analysis
6.4.1. Antibodies
6.4.2. Hormones
6.4.3. Growth Factors
6.4.4. Enzyme
6.4.5. Cytokines
6.4.6. Others
Chapter 7. Global Recombinant Proteins Market, by Application
7.1. Market Snapshot
7.2. Global Recombinant Proteins Market by Application, Performance - Potential Analysis
7.3. Global Recombinant Proteins Market Estimates & Forecasts by Application 2019-2028 (USD Million)
7.4. Recombinant Proteins Market, Sub Segment Analysis
7.4.1. Drug Discovery & Development
7.4.2. Biopharmaceutical Production
7.4.3. Biotechnology Research
7.4.4. Academic Research Studies
7.4.5. Other Applications
Chapter 8. Global Recombinant Proteins Market, by End User
8.1. Market Snapshot
8.2. Global Recombinant Proteins Market by End User, Performance - Potential Analysis
8.3. Global Recombinant Proteins Market Estimates & Forecasts by End User 2019-2028 (USD Million)
8.4. Recombinant Proteins Market, Sub Segment Analysis
8.4.1. Pharmaceutical & Biopharmaceutical Companies
8.4.2. Biotechnology Companies
8.4.3. Academic Research Institutes
8.4.4. Contract Research Organizations
8.4.5. Other End Users
Chapter 9. Global Recombinant Proteins Market, Regional Analysis
9.1. Recombinant Proteins Market, Regional Market Snapshot
9.2. North America Recombinant Proteins Market
9.2.1. U.S. Recombinant Proteins Market
9.2.1.1. Product estimates & forecasts, 2019-2028
9.2.1.2. Application estimates & forecasts, 2019-2028
9.2.1.3. End User estimates & forecasts, 2019-2028
9.2.2. Canada Recombinant Proteins Market
9.3. Europe Recombinant Proteins Market Snapshot
9.3.1. U.K. Recombinant Proteins Market
9.3.2. Germany Recombinant Proteins Market
9.3.3. France Recombinant Proteins Market
9.3.4. Spain Recombinant Proteins Market
9.3.5. Italy Recombinant Proteins Market
9.3.6. Rest of Europe Recombinant Proteins Market
9.4. Asia-Pacific Recombinant Proteins Market Snapshot
9.4.1. China Recombinant Proteins Market
9.4.2. India Recombinant Proteins Market
9.4.3. Japan Recombinant Proteins Market
9.4.4. Australia Recombinant Proteins Market
9.4.5. South Korea Recombinant Proteins Market
9.4.6. Rest of Asia Pacific Recombinant Proteins Market
9.5. Latin America Recombinant Proteins Market Snapshot
9.5.1. Brazil Recombinant Proteins Market
9.5.2. Mexico Recombinant Proteins Market
9.6. Rest of The World Recombinant Proteins Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Thermo Fisher Scientific, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Miltenyi Biotech
10.2.3. Sino Biological Inc.
10.2.4. Bio-Rad Laboratories, Inc.
10.2.5. Enzo Life Sciences, Inc.
10.2.6. BPS Bioscience, Inc.
10.2.7. Stemcell Technologies Inc
10.2.8. RayBiotech Inc
10.2.9. Richcore Lifesciences Pvt Ltd
10.2.10. United States Biological
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
TABLE 1. Global Recombinant Proteins Market, report scope
TABLE 2. Global Recombinant Proteins Market estimates & forecasts by Region 2019-2028 (USD Million)
TABLE 3. Global Recombinant Proteins Market estimates & forecasts by Product 2019-2028 (USD Million)
TABLE 4. Global Recombinant Proteins Market estimates & forecasts by Application 2019-2028 (USD Million)
TABLE 5. Global Recombinant Proteins Market estimates & forecasts by End User 2019-2028 (USD Million)
TABLE 6. Global Recombinant Proteins Market by segment, estimates & forecasts, 2019-2028 (USD Million)
TABLE 7. Global Recombinant Proteins Market by region, estimates & forecasts, 2019-2028 (USD Million)
TABLE 8. Global Recombinant Proteins Market by segment, estimates & forecasts, 2019-2028 (USD Million)
TABLE 9. Global Recombinant Proteins Market by region, estimates & forecasts, 2019-2028 (USD Million)
TABLE 10. Global Recombinant Proteins Market by segment, estimates & forecasts, 2019-2028 (USD Million)
TABLE 11. Global Recombinant Proteins Market by region, estimates & forecasts, 2019-2028 (USD Million)
TABLE 12. Global Recombinant Proteins Market by segment, estimates & forecasts, 2019-2028 (USD Million)
TABLE 13. Global Recombinant Proteins Market by region, estimates & forecasts, 2019-2028 (USD Million)
TABLE 14. Global Recombinant Proteins Market by segment, estimates & forecasts, 2019-2028 (USD Million)
TABLE 15. Global Recombinant Proteins Market by region, estimates & forecasts, 2019-2028 (USD Million)
TABLE 16. U.S. Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 17. U.S. Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 18. U.S. Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 19. Canada Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 20. Canada Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 21. Canada Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 22. UK Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 23. UK Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 24. UK Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 25. Germany Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 26. Germany Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 27. Germany Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 28. RoE Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 29. RoE Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 30. RoE Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 31. China Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 32. China Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 33. China Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 34. India Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 35. India Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 36. India Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 37. Japan Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 38. Japan Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 39. Japan Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 40. RoAPAC Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 41. RoAPAC Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 42. RoAPAC Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 43. Brazil Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 44. Brazil Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 45. Brazil Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 46. Mexico Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 47. Mexico Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 48. Mexico Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 49. RoLA Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 50. RoLA Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 51. RoLA Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 52. Row Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 53. Row Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 54. Row Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 55. List of secondary sources, used in the study of global Recombinant Proteins Market
TABLE 56. List of primary sources, used in the study of global Recombinant Proteins Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
Similar Reports
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
- Publish Date: February 7, 2017
- $750
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
- Publish Date: February 7, 2017
- $750
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...
- Publish Date: February 7, 2017
- $750
